MLICM
ACET icon

Metropolitan Life Insurance Company (MetLife)’s Adicet Bio ACET Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-82
Closed -$3.21K – 2400
2023
Q2 		$3.21K Hold
82
– – ﹤0.01% 2453
2023
Q1 		$7.6K Sell
82
-50
-38% -$6.28K ﹤0.01% 2232
2022
Q4 		$18.8K Buy
132
+37
+39% +$9.23K ﹤0.01% 2048
2022
Q3 		$21.7K Hold
95
– – ﹤0.01% 1992
2022
Q2 		$22.2K Hold
95
– – ﹤0.01% 1998
2022
Q1 		$30.4K Sell
95
-285
-75% -$65.6K ﹤0.01% 1874
2021
Q4 		$106K Buy
+380
New +$65.2K ﹤0.01% 2442

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACET Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 82 shares — an estimated $3.21K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACET in Q4 2021 and held it in 7 quarters. The position peaked at $106K in Q4 2021. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 82 Adicet Bio shares in Q3 2023, an estimated $3.21K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Adicet Bio in Q4 2021 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Adicet Bio position peaked at $106K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.